Showing results (11-20 of 51) with videos related to

Sort By:
Pageof 6
Journal of the American Academy of Dermatology|July 29, 2008
Extracorporeal photopheresis for the treatment of Sézary syndrome using a novel treatment protocolSuzanne Arulogun, H Miles Prince, Peter Gambell, et al.
BMC Gastroenterology|April 22, 2022
CD10 and Das1: a biomarker study using immunohistochemistry to subtype gastric intestinal metaplasiaAthanasios Koulis, Natasha Di Costanzo, Catherine Mitchell, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 9, 2013
High FDG activity in focal fat necrosis: a pitfall in interpretation of posttreatment PET/CT in patients with non-Hodgkin lymphomaRaghava Kashyap, Eddie Lau, Anupkumar George, et al.
Blood|July 24, 2008
Long-term outcomes of patients with advanced-stage cutaneous T-cell lymphoma and large cell transformationSuzanne O Arulogun, H Miles Prince, Jonathan Ng, et al.
ANZ Journal of Surgery|November 13, 2014
Predictors of outcome after surgery for gastric cancer in a Western cohortSharon Pattison, G Bruce Mann, Gary Crosthwaite, et al.
Journal of Clinical Pathology|August 27, 2015
Role of immunohistochemistry in the era of genetic testing in MYC-positive aggressive B-cell lymphomas: a study of 209 casesRishu Agarwal, Stephen Lade, Danny Liew, et al.
The Australasian Journal of Dermatology|December 17, 2025
Cutaneous Infiltration of Waldenstrom's Macroglobulinaemia-A Two-Case Series of a Diagnostically Challenging PresentationMonica Narula, Patrick D Mahar, Edwin Wee Hian Tan, et al.
International Journal of Molecular Sciences|June 15, 2018
Molecular Mechanisms of Disease Progression in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type during Ibrutinib TherapyLucy C Fox, Costas K Yannakou, Georgina Ryland, et al.
The Australasian Journal of Dermatology|March 9, 2023
CD30-positive lymphoproliferative disorders-An Australian Clinical Practice Statement from the Peter MacCallum Cancer CentreFriyana K Bhabha, Christopher McCormack, Belinda A Campbell, et al.
Cancer|March 23, 2011
Breast implant-associated, ALK-negative, T-cell, anaplastic, large-cell lymphoma: establishment and characterization of a model cell line (TLBR-1) for this newly emerging clinical entityMelissa G Lechner, Stephen Lade, Daniel J Liebertz, et al.
Pageof 6